Genetically Engineered Lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Genetically Engineered Lymphocytes, covering 2014-08-06 to 2014-08-06. Get the full timeline:
Most recent: Clinical Trial Update: Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma [Phase 1]